Meet our CEO prof. Jacek Jemielity among other Polish innovators at the Polish Healthcare Assets Sector Event. Prof. Jemielity will take part in a panel discussing how technology invented and developed in Poland can change the global Life Science market.…
Funding from the Bill & Melinda Gates Foundation will go toward understanding the benefits o novel cap analogs for therapeutic applications.Warsaw, December 8, 2022. ExPLoRNA Therapeutics, a Polish biotech company revolutionizing mRNA vaccines and therapeutics with unprecedented translational efficiency, received…
We appreciate the recognition of Explorna Therapeutics’s contribution to the development of the biotech industry in the region of Mazovia.
We are looking forward to exploring the rapidly advancing mRNA technology together with other conference participants during 9th Annual International mRNA Health Conference. The International mRNA Health Conference (Conference Days November 9 and 10, 2021) is the premier meeting destination…
The FNP Prize honors for outstanding achievements and scientific discoveries that push the boundaries of cognition and open new research perspectives, provide an exceptional contribution to Poland’s civilizational and cultural advancement, and assure the country with a significant position for…
The aim of the Mazovia Innovator Award is to select and reward young talents among researchers and companies from the micro, small and medium-sized enterprises sector that have developed and implemented innovative solutions in the Mazovia region. It’s a great…
In the publication, the researchers from the University of Warsaw under the supervision of prof. Jacek Jemielity described a new method for increasing messenger RNAs (mRNAs) translation. In the mRNAs used so far, the most used first nucleotide transcribed is…